Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a group course teach young adults to connect?

NCT ID NCT07820020

Symptom relief Sponsor: Korea University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers at Korea University are testing an 8-week group social skills training program for young adults aged 19 to 34 who report loneliness and difficulty in social situations. The program combines weekly 120-minute face-to-face sessions with a web platform for practice between meetings. Participants are randomly assigned to start the program or to a waitlist, and researchers measure social skills, social performance, and loneliness before, after, and one month later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an 8-week group social skills training program with digital support
What this could lead to
If it works, this could offer a structured, non-drug option for young adults who struggle with loneliness and social isolation.
What could go wrong
The trial is small and early, and social skills training may not suit everyone or produce lasting change. Participants must attend weekly sessions and practice between them, which takes effort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 34 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 to 34 years * South Korean nationality * Interpersonal Competence Questionnaire, 15-item short form (ICQ-15): mean score of 2.87 or lower * Meets either (a) or (b) below: * (a) Lubben Social Network Scale-6 (LSNS-6) total score of less than 12, AND short-form UCLA Loneliness Scale-8 total score of 17 or higher * (b) Korea University Social Isolation Scale (KUSIS) total score of 9 or higher * Confirmation on a non-face-to-face screening interview that the participant's primary difficulty involves interpersonal problems stemming from a lack of social knowledge and skills Exclusion Criteria: * Psychiatric or neurological hospitalization within the past 6 months * Current or past diagnosis of a severe neurological disorder * Cognitive impairment severe enough to hinder the basic communication required for program participation * Suicide attempt within the past 6 months * Severe suicide risk identified during the assessment * History of psychotic symptoms or manic episodes * Severe psychiatric condition or major medical abnormality that would complicate participation * Unable or unwilling to follow the research team's instructions during the application process * Currently participating in individual or group psychotherapy that provides training in other social skills * Participation within the past 5 years in a study on social isolation conducted by an investigator of the present research team, which raises concern for a confounding effect on the study results

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Loneliness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Social Isolation Social Skills

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Loneliness Social isolation Social skills

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.